McMaster researchers, biopharmaceutical company Boehringer Ingelheim (Canada) Ltd. and St. Joseph’s Healthcare Hamilton have developed a kit that offers support and resources for people recently diagnosed with ILD.
A bioengineered lung model that can respond to viruses and drug treatments will advance our understanding of lung disease and biology, say researchers.
Five ways universities can support health research that responds to societal needs, and continue the fast-paced collaborative research and innovation we have seen during the pandemic.